CPS Technologies (CPSH) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
29 Jan, 2026Executive summary
Achieved record quarterly revenue of $7.5 million in Q1 2025, up 27% year-over-year, driven by expanded production, strong demand for AlSiC and hermetic packaging, and new Army SBIR contracts, despite no armor sales this quarter.
Operating profit reached $130,000, reversing a prior year operating loss of $260,000.
Net income was just under $100,000, or $0.01 per share, compared to a net loss last year.
SG&A expenses decreased 6% year-over-year due to cost control efforts.
Company is optimistic about continued margin and profitability improvements in 2025, focusing on advanced material solutions for electronics, automotive, and defense.
Financial highlights
Product sales reached $7,505,921 in Q1 2025, up from $5,912,634 in Q1 2024.
Gross profit rose to $1,231,001 (16.4% margin) from $906,310 (15.3% margin) last year.
Net income was $95,962 in Q1 2025, or $0.01 per share.
Cash and cash equivalents at quarter-end were $1,929,919, with $1 million in marketable securities.
Accounts receivable and inventories increased in line with revenue growth.
Outlook and guidance
Management anticipates continued strong top-line performance and margin expansion throughout 2025, supported by higher production volumes and recent contract wins.
Expects further growth in both margins and profitability as production efficiencies improve.
New market opportunities in wind farms, high-voltage DC transmission, and clean energy are expected to drive future growth.
Ongoing product development and commercialization efforts in hybrid tech radiation shielding and fiber-reinforced aluminum.
Management expects to fund operations for the remainder of 2025 from existing cash and operations.
Latest events from CPS Technologies
- 2026 meeting seeks approval for directors, executive pay, share increase, and auditor ratification.CPSH
Proxy filing20 Mar 2026 - Annual meeting to vote on directors, executive pay, share increase, and auditor ratification.CPSH
Proxy Filing10 Mar 2026 - Record revenue, margin gains, and facility expansion drive strong growth outlook.CPSH
Q4 20253 Mar 2026 - Revenue and margins fell in Q2, but new contracts and product launches support future growth.CPSH
Q2 20242 Feb 2026 - Record Q2 2025 revenue, profitability, and strong demand drive a positive outlook.CPSH
Q2 202529 Jan 2026 - Record revenue, margin gains, and a $9.5M raise drive expansion and strong growth outlook.CPSH
Q3 202529 Jan 2026 - Q3 revenue fell 32% to $4.2M, but new contracts and capacity boost outlook for 2025.CPSH
Q3 202429 Jan 2026 - Record revenue, $12M order, and new contracts drive growth and innovation outlook.CPSH
21st Virtual Investor Summit Microcap Event12 Jan 2026 - Sequential revenue growth and new contracts position the company for a stronger 2025.CPSH
Q4 202426 Dec 2025